This announcement is a separate document:
海南葫芦娃药业集团股份有限公司关于全资子公司获得布洛芬混悬滴剂药品注册证书的公告
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. about its wholly-owned subsidiary obtaining the registration certificate for ibuprofen suspension drip pharmaceutical.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.